Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder

NCT01299272 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01299272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01299272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
November 30, 2013
Enrollment
1,249 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder